首页> 外文期刊>Journal of Optometry >Current applications and efficacy of scleral contact lenses - a retrospective study
【24h】

Current applications and efficacy of scleral contact lenses - a retrospective study

机译:巩膜隐形眼镜的当前应用和功效-回顾性研究

获取原文
       

摘要

Purpose: To evaluate the indications and efficacy of high gas permeable scleral contact lenses (GP-SCL). Methods: A total database of 97 consecutive patients (140 eyes) fitted with GP-SCL between January 2003 and December 2008, was retrospectively analyzed to determine the benefits of fitting scleral lenses. All lenses were fitted by preformed technique and were non-fenestrated. Patients included keratoconus - 88 eyes (63 %); corneal irregularities after penetrating keratoplasty - 39 eyes (28 %); various ocular surface disorders: Stevens-Johnson syndrome (SJS), graft versus host disease (GVHD) and exposure keratopathy - 6 eyes (4 %); post refractive surgery keratoectasia - 4 eyes (3 %), and high refractive error - 3 eyes (2 %). Results: Mean follow up was 27.5 months (range 1-71), mean wearing time in successful wearers group was 12.2 hours per day (range 10-16), mean wearing time in group of wearers who dropped out using GP-SCL, was 5.8 hours (range 3-8). Keratoconus patients achieved median best corrected visual acuity (BCVA) of 20/32, 84 % of patients achieved BCVA of 20/40 or more. The post keratoplasty group achieved median BCVA of 20/25, 92 % of patients achieved BCVA of 20/40 or better. In the other groups, median BCVA was as follows: ocular surface disorders - 20/50, keratoectasia - 20/30, high refractive error - 20/32. Positive fluid-venting was highly associated with successful GP-SCL wearing. Twenty patients (21 %) failed to wear GP-SCL. Conclusions: GP-SCL's expand the management of various corneal abnormalities. The main indication for GP-SCL is optical correction of an irregular corneal surface, especially keratoconus and corneal transplant.
机译:目的:评估高透气性巩膜接触镜(GP-SCL)的适应症和疗效。方法:回顾性分析2003年1月至2008年12月期间共97例(140眼)连续性GP-SCL患者的资料,以确定采用巩膜镜片的好处。所有镜片均通过预制技术进行装配,并且没有开窗。患者包括圆锥角膜-88只眼(63%);穿透性角膜移植术后角膜不规则-39眼(28%);多种眼表疾病:史蒂文斯-约翰逊综合征(SJS),移植物抗宿主病(GVHD)和暴露性角膜病变-6眼(4%);屈光手术后角膜扩张-4眼(3%),高屈光不正-3眼(2%)。结果:平均随访时间为27.5个月(范围为1-71),成功佩戴者组的平均佩戴时间为每天12.2小时(范围为10-16),使用GP-SCL退学的佩戴者组的平均佩戴时间为5.8小时(范围3-8)。圆锥角膜患者的中位最佳矫正视力(BCVA)为20 / 32,84%的患者BCVA为20/40或更高。角膜移植术后组的BCVA中位数为20 / 25,92%的患者BCVA为20/40或更高。在其他组中,中位BCVA如下:眼表疾病-20/50,角膜扩张-20/30,高屈光不正-20/32。积极的排空与GP-SCL的成功佩戴高度相关。 20名患者(21%)未能佩戴GP-SCL。结论:GP-SCL扩大了对各种角膜异常的处理。 GP-SCL的主要适应症是对不规则角膜表面进行光学矫正,尤其是圆锥角膜和角膜移植。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号